448 related articles for article (PubMed ID: 26695395)
21. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
Barbato M; D'Angelo E; Di Loreto G; Menna A; Di Francesco A; Salini V; Zoppi U; Cavasinni L; La Floresta P; Romanò CL
J Orthop Traumatol; 2012 Jun; 13(2):63-7. PubMed ID: 22358779
[TBL] [Abstract][Full Text] [Related]
22. Heterotopic Ossification Prophylaxis After Total Hip Arthroplasty: Randomized Trial of 400 vs 700 cGy.
Liu JZ; Frisch NB; Barden RM; Rosenberg AG; Silverton CD; Galante JO
J Arthroplasty; 2017 Apr; 32(4):1328-1334. PubMed ID: 27884418
[TBL] [Abstract][Full Text] [Related]
23. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
25. [Tranexamic Acid Reduces the Incidence of Heterotopic Ossifications after Elective Primary Total Hip Arthroplasty].
Debre J; Štěpán Z; Dupal J
Acta Chir Orthop Traumatol Cech; 2021; 88(1):13-17. PubMed ID: 33764862
[TBL] [Abstract][Full Text] [Related]
26. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
[TBL] [Abstract][Full Text] [Related]
27. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Brunnekreef JJ; Hoogervorst P; Ploegmakers MJ; Rijnen WH; Schreurs BW
Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100
[TBL] [Abstract][Full Text] [Related]
28. Chemoprophylaxis for heterotopic ossification following hip arthroscopy: A systematic review.
Dean RS; Hamama BA; Cavinatto L; Nho SJ; Chahla J; Hinckel BB
J ISAKOS; 2023 Dec; 8(6):484-489. PubMed ID: 37619960
[TBL] [Abstract][Full Text] [Related]
29. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study.
Schneider J; Maffulli N; Eschweiler J; Bell A; Hildebrand F; Migliorini F
Sci Rep; 2023 Nov; 13(1):20210. PubMed ID: 37980449
[TBL] [Abstract][Full Text] [Related]
31. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
32. Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients.
Seegenschmiedt MH; Martus P; Goldmann AR; Wölfel R; Keilholz L; Sauer R
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):63-73. PubMed ID: 8083130
[TBL] [Abstract][Full Text] [Related]
33. Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
Kan SL; Yang B; Ning GZ; Chen LX; Li YL; Gao SJ; Chen XY; Sun JC; Feng SQ
Medicine (Baltimore); 2015 May; 94(18):e828. PubMed ID: 25950691
[TBL] [Abstract][Full Text] [Related]
34. Heterotopic ossification after arthroscopy for hip impingement syndrome.
Gao GY; Zhang X; Dai LH; Huang HJ; Wu RQ; Ju XD; Mei Y; Niu XY; Wang JQ; Xu Y
Chin Med J (Engl); 2019 Apr; 132(7):827-833. PubMed ID: 30897596
[TBL] [Abstract][Full Text] [Related]
35. The incidence of heterotopic ossification in hip arthroscopy.
Rath E; Sherman H; Sampson TG; Ben Tov T; Maman E; Amar E
Arthroscopy; 2013 Mar; 29(3):427-33. PubMed ID: 23351728
[TBL] [Abstract][Full Text] [Related]
36. Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study.
Oni JK; Pinero JR; Saltzman BM; Jaffe FF
Hip Int; 2014; 24(3):256-62. PubMed ID: 24474408
[TBL] [Abstract][Full Text] [Related]
37. Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment.
Łęgosz P; Otworowski M; Sibilska A; Starszak K; Kotrych D; Kwapisz A; Synder M
Biomed Res Int; 2019; 2019():3860142. PubMed ID: 31119167
[TBL] [Abstract][Full Text] [Related]
38. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
Barthel T; Baumann B; Nöth U; Eulert J
Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
[TBL] [Abstract][Full Text] [Related]
39. Incidence and location of heterotopic ossification following hip arthroscopy.
Zheng L; Hwang JM; Hwang DS; Kang C; Lee JK; Park YC
BMC Musculoskelet Disord; 2020 Feb; 21(1):132. PubMed ID: 32111223
[TBL] [Abstract][Full Text] [Related]
40. Heterotopic ossification is less after THA in patients who receive aspirin compared to coumadin.
Cohn RM; Della Valle AG; Cornell CN
Bull NYU Hosp Jt Dis; 2010; 68(4):266-72. PubMed ID: 21162704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
